The store will not work correctly when cookies are disabled.
4-bromo-2-(4-bromo-2-hydroxybenzylideneamino)phenylimino)methyl)phenol
ID: ALA2238552
PubChem CID: 136249270
Max Phase: Preclinical
Molecular Formula: C20H14Br2N2O2
Molecular Weight: 474.15
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1cc(Br)ccc1/C=N\c1ccccc1/N=C/c1cc(Br)ccc1O
Standard InChI: InChI=1S/C20H14Br2N2O2/c21-15-7-8-19(25)14(9-15)12-24-18-4-2-1-3-17(18)23-11-13-5-6-16(22)10-20(13)26/h1-12,25-26H/b23-11-,24-12+
Standard InChI Key: ZYHIWRDQIRYRBT-QEUMEHMPSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
13.2846 -17.1893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9917 -16.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7000 -17.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6971 -18.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4047 -18.4105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1127 -18.0007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1088 -17.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4007 -16.7756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0496 -17.1940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0484 -18.0135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7565 -18.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4662 -18.0131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4633 -17.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7547 -16.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1745 -18.4205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8816 -18.0108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5899 -18.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1695 -16.7791 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5866 -19.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2941 -19.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0021 -19.2316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9982 -18.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2901 -18.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3954 -15.9584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3404 -18.4216 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
16.8216 -18.4072 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 2 0
16 17 1 0
13 18 1 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
23 1 1 0
8 24 1 0
10 25 1 0
6 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 474.15 | Molecular Weight (Monoisotopic): 471.9422 | AlogP: 6.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 65.18 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.47 | CX Basic pKa: 0.40 | CX LogP: 6.65 | CX LogD: 6.35 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: -0.49 |
References
1. Misra S, Pandeya KB, Tiwari AK, Ali AZ, Saradamani T, Agawane SB, Madhusudana K. (2011) Antihyperglycemic, -glucosidase inhibitory and DPPH free radical scavenging activity of 5-bromosalicylaldehyde and schiff bases, 20 (9): [10.1007/s00044-010-9377-3] |